SP-8356: Clinical Trials

1 trial of SP-8356, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow SP-8356: new trials by email Literature Review of SP-8356 trials Research Report on SP-8356

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Study to Evaluate Safety and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8356
SP-8356, Placebo - Atherosclerosis, Ischemic Stroke
Phase 1TerminatedShin Poong Pharmaceutical Co. Ltd.312021-01-032022-10-10

Conditions studied

Atherosclerosis (1)  ·  Ischemic Stroke (1)

Sponsors

Shin Poong Pharmaceutical Co. Ltd. (1)

Countries

United Kingdom (1)

Top investigators

Stuart Mair, MD, PhD (1)